Insights from 2024 ESGO Annual Meeting
Video Player is loading.
10 seconds
Playback speed
ESGO 2024 Insights: "SENTIX Trial - Survival of Patients With Early Stages Cervical Cancer After SLN Biopsy Without Systematic Pelvic Lymphadenectomy"
By
Insights from 2024 ESGO Annual Meeting
FEATURING
David Cibula
By
Insights from 2024 ESGO Annual Meeting
FEATURING
David Cibula
Comments 0
Login to view comments.
Click here to Login
